Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Feb 29, 2024
Feb 28, 2024
Feb 13, 2024
Events
Mar 6, 2024 at 2:50 PM EST
May 23, 2023 at 9:00 AM EDT
SEC Filings
| Filing date | Description | Form |
|---|---|---|
| D | ||
| D | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |